Drug Profile
Tc 99m exametazime - Jubilant DraxImage
Alternative Names: Drax Exametazime; Technetium 99m exametazime - Jubilant DraxImage; Technetium Tc 99m exametazime - Jubilant DraxImageLatest Information Update: 18 Jan 2018
Price :
$50
*
At a glance
- Originator Jubilant DraxImage
- Class Oximes; Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Intra-abdominal infections; Irritable bowel syndrome
Most Recent Events
- 18 Jan 2018 Jubilant DraxImage anticipates Tc 99m exametazime launch in USA in March 2018 (Email communication with Jubilant DraxImage)
- 07 Sep 2017 Chemical structure information added
- 17 Aug 2017 Registered for Intra-abdominal infections (Diagnosis) in USA (IV) (US FDA Approval letter, August 2017)